Many efforts to develop vaccines and therapies to thwart SARS-CoV-2 focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to allow viral entry. Now, researchers have uncovered an active role for glycans -- sugar molecules that can decorate proteins -- in this process, suggesting targets for vaccines and therapies.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200923090426.htm
No comments:
Post a Comment